The global Medical Isotopes market size was valued at US$ 760.6 million in 2023. With growing demand in downstream market, the Medical Isotopes is forecast to a readjusted size of US$ 990 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Medical Isotopes market. Medical Isotopes are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Medical Isotopes. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Medical Isotopes market.
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a 'cold' process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.
North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990鈥檚 other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.
Key Features:
The report on Medical Isotopes market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Medical Isotopes market. It may include historical data, market segmentation by Type (e.g., Stable Isotopes, Radioisotopes), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Medical Isotopes market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Medical Isotopes market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Medical Isotopes industry. This include advancements in Medical Isotopes technology, Medical Isotopes new entrants, Medical Isotopes new investment, and other innovations that are shaping the future of Medical Isotopes.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Medical Isotopes market. It includes factors influencing customer ' purchasing decisions, preferences for Medical Isotopes product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Medical Isotopes market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Medical Isotopes market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Medical Isotopes market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Medical Isotopes industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Medical Isotopes market.
麻豆原创 Segmentation:
Medical Isotopes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Stable Isotopes
Radioisotopes
Segmentation by application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Medical Isotopes 麻豆原创 Size 2019-2030
2.1.2 Medical Isotopes 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Medical Isotopes Segment by Type
2.2.1 Stable Isotopes
2.2.2 Radioisotopes
2.3 Medical Isotopes 麻豆原创 Size by Type
2.3.1 Medical Isotopes 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Medical Isotopes 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Medical Isotopes Segment by Application
2.4.1 Nuclear Therapy
2.4.2 Equipment Radioactive Source
2.4.3 Diagnosis
2.5 Medical Isotopes 麻豆原创 Size by Application
2.5.1 Medical Isotopes 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Medical Isotopes 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Medical Isotopes 麻豆原创 Size by Player
3.1 Medical Isotopes 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Medical Isotopes Revenue by Players (2019-2024)
3.1.2 Global Medical Isotopes Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Medical Isotopes Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Medical Isotopes by Regions
4.1 Medical Isotopes 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Medical Isotopes 麻豆原创 Size Growth (2019-2024)
4.3 APAC Medical Isotopes 麻豆原创 Size Growth (2019-2024)
4.4 Europe Medical Isotopes 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Medical Isotopes 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Medical Isotopes 麻豆原创 Size by Country (2019-2024)
5.2 Americas Medical Isotopes 麻豆原创 Size by Type (2019-2024)
5.3 Americas Medical Isotopes 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Isotopes 麻豆原创 Size by Region (2019-2024)
6.2 APAC Medical Isotopes 麻豆原创 Size by Type (2019-2024)
6.3 APAC Medical Isotopes 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Medical Isotopes by Country (2019-2024)
7.2 Europe Medical Isotopes 麻豆原创 Size by Type (2019-2024)
7.3 Europe Medical Isotopes 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Isotopes by Region (2019-2024)
8.2 Middle East & Africa Medical Isotopes 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Medical Isotopes 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Medical Isotopes 麻豆原创 Forecast
10.1 Global Medical Isotopes Forecast by Regions (2025-2030)
10.1.1 Global Medical Isotopes Forecast by Regions (2025-2030)
10.1.2 Americas Medical Isotopes Forecast
10.1.3 APAC Medical Isotopes Forecast
10.1.4 Europe Medical Isotopes Forecast
10.1.5 Middle East & Africa Medical Isotopes Forecast
10.2 Americas Medical Isotopes Forecast by Country (2025-2030)
10.2.1 United States Medical Isotopes 麻豆原创 Forecast
10.2.2 Canada Medical Isotopes 麻豆原创 Forecast
10.2.3 Mexico Medical Isotopes 麻豆原创 Forecast
10.2.4 Brazil Medical Isotopes 麻豆原创 Forecast
10.3 APAC Medical Isotopes Forecast by Region (2025-2030)
10.3.1 China Medical Isotopes 麻豆原创 Forecast
10.3.2 Japan Medical Isotopes 麻豆原创 Forecast
10.3.3 Korea Medical Isotopes 麻豆原创 Forecast
10.3.4 Southeast Asia Medical Isotopes 麻豆原创 Forecast
10.3.5 India Medical Isotopes 麻豆原创 Forecast
10.3.6 Australia Medical Isotopes 麻豆原创 Forecast
10.4 Europe Medical Isotopes Forecast by Country (2025-2030)
10.4.1 Germany Medical Isotopes 麻豆原创 Forecast
10.4.2 France Medical Isotopes 麻豆原创 Forecast
10.4.3 UK Medical Isotopes 麻豆原创 Forecast
10.4.4 Italy Medical Isotopes 麻豆原创 Forecast
10.4.5 Russia Medical Isotopes 麻豆原创 Forecast
10.5 Middle East & Africa Medical Isotopes Forecast by Region (2025-2030)
10.5.1 Egypt Medical Isotopes 麻豆原创 Forecast
10.5.2 South Africa Medical Isotopes 麻豆原创 Forecast
10.5.3 Israel Medical Isotopes 麻豆原创 Forecast
10.5.4 Turkey Medical Isotopes 麻豆原创 Forecast
10.5.5 GCC Countries Medical Isotopes 麻豆原创 Forecast
10.6 Global Medical Isotopes Forecast by Type (2025-2030)
10.7 Global Medical Isotopes Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 NRG
11.1.1 NRG Company Information
11.1.2 NRG Medical Isotopes Product Offered
11.1.3 NRG Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 NRG Main Business Overview
11.1.5 NRG Latest Developments
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Information
11.2.2 NTP Radioisotopes Medical Isotopes Product Offered
11.2.3 NTP Radioisotopes Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 NTP Radioisotopes Main Business Overview
11.2.5 NTP Radioisotopes Latest Developments
11.3 JSC Isotope
11.3.1 JSC Isotope Company Information
11.3.2 JSC Isotope Medical Isotopes Product Offered
11.3.3 JSC Isotope Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 JSC Isotope Main Business Overview
11.3.5 JSC Isotope Latest Developments
11.4 ANSTO
11.4.1 ANSTO Company Information
11.4.2 ANSTO Medical Isotopes Product Offered
11.4.3 ANSTO Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 ANSTO Main Business Overview
11.4.5 ANSTO Latest Developments
11.5 IRE
11.5.1 IRE Company Information
11.5.2 IRE Medical Isotopes Product Offered
11.5.3 IRE Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 IRE Main Business Overview
11.5.5 IRE Latest Developments
11.6 Nordion
11.6.1 Nordion Company Information
11.6.2 Nordion Medical Isotopes Product Offered
11.6.3 Nordion Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Nordion Main Business Overview
11.6.5 Nordion Latest Developments
11.7 Curium Pharma
11.7.1 Curium Pharma Company Information
11.7.2 Curium Pharma Medical Isotopes Product Offered
11.7.3 Curium Pharma Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Curium Pharma Main Business Overview
11.7.5 Curium Pharma Latest Developments
11.8 Cambridge Isotope Laboratories
11.8.1 Cambridge Isotope Laboratories Company Information
11.8.2 Cambridge Isotope Laboratories Medical Isotopes Product Offered
11.8.3 Cambridge Isotope Laboratories Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Cambridge Isotope Laboratories Main Business Overview
11.8.5 Cambridge Isotope Laboratories Latest Developments
11.9 Eckert & Ziegler Strahlen
11.9.1 Eckert & Ziegler Strahlen Company Information
11.9.2 Eckert & Ziegler Strahlen Medical Isotopes Product Offered
11.9.3 Eckert & Ziegler Strahlen Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Eckert & Ziegler Strahlen Main Business Overview
11.9.5 Eckert & Ziegler Strahlen Latest Developments
11.10 Polatom
11.10.1 Polatom Company Information
11.10.2 Polatom Medical Isotopes Product Offered
11.10.3 Polatom Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Polatom Main Business Overview
11.10.5 Polatom Latest Developments
11.11 Center of Molecular Research
11.11.1 Center of Molecular Research Company Information
11.11.2 Center of Molecular Research Medical Isotopes Product Offered
11.11.3 Center of Molecular Research Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Center of Molecular Research Main Business Overview
11.11.5 Center of Molecular Research Latest Developments
11.12 China National Nuclear Corporation
11.12.1 China National Nuclear Corporation Company Information
11.12.2 China National Nuclear Corporation Medical Isotopes Product Offered
11.12.3 China National Nuclear Corporation Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 China National Nuclear Corporation Main Business Overview
11.12.5 China National Nuclear Corporation Latest Developments
11.13 Urenco
11.13.1 Urenco Company Information
11.13.2 Urenco Medical Isotopes Product Offered
11.13.3 Urenco Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Urenco Main Business Overview
11.13.5 Urenco Latest Developments
11.14 LANL
11.14.1 LANL Company Information
11.14.2 LANL Medical Isotopes Product Offered
11.14.3 LANL Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 LANL Main Business Overview
11.14.5 LANL Latest Developments
11.15 Shanghai Engineering Research Center
11.15.1 Shanghai Engineering Research Center Company Information
11.15.2 Shanghai Engineering Research Center Medical Isotopes Product Offered
11.15.3 Shanghai Engineering Research Center Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Shanghai Engineering Research Center Main Business Overview
11.15.5 Shanghai Engineering Research Center Latest Developments
11.16 IDB Holland
11.16.1 IDB Holland Company Information
11.16.2 IDB Holland Medical Isotopes Product Offered
11.16.3 IDB Holland Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 IDB Holland Main Business Overview
11.16.5 IDB Holland Latest Developments
11.17 NHTC
11.17.1 NHTC Company Information
11.17.2 NHTC Medical Isotopes Product Offered
11.17.3 NHTC Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 NHTC Main Business Overview
11.17.5 NHTC Latest Developments
11.18 Linde
11.18.1 Linde Company Information
11.18.2 Linde Medical Isotopes Product Offered
11.18.3 Linde Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 Linde Main Business Overview
11.18.5 Linde Latest Developments
11.19 ORNL
11.19.1 ORNL Company Information
11.19.2 ORNL Medical Isotopes Product Offered
11.19.3 ORNL Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 ORNL Main Business Overview
11.19.5 ORNL Latest Developments
11.20 SI Science
11.20.1 SI Science Company Information
11.20.2 SI Science Medical Isotopes Product Offered
11.20.3 SI Science Medical Isotopes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 SI Science Main Business Overview
11.20.5 SI Science Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
